1. Beckman J A, Creager M A and Libby P. Diabetes and
atherosclerosis: epidemiology, pathophysiology, and management. The
Journal of the American Medical Association 2002;287:2570-2581.
2. Bucala R, Makita Z, Koschinsky T, et al. Lipid advanced
glycosylation: pathway for lipid oxidation in vivo. Proceedings of the
National Academy of Sciences. 1993;90:6434-6438.
3. Napoli C, Triggiani M, Palumbo G, et al. Glycosylation enhances
oxygen radical-induced modifications and decreases acetylhydrolase
activity of human low density lipoprotein. Basic research in
cardiology. 1997;92:96-105.
4. Libby P, Buring J E, Badimon L, et al. Atherosclerosis (Primer).
Nature Reviews: Disease Primers. 2019.
5. Palasubramaniam J, Wang X and Peter K. Myocardial Infarction—From
Atherosclerosis to Thrombosis: Uncovering New Diagnostic and
Therapeutic Approaches. Arteriosclerosis, thrombosis, and vascular
biology. 2019;39:e176-e185.
6. Guide to HbA1c. Diabetes.co.uk, 15 de enero de 2019. https://www.diabetes.co.uk/what-is-hba1c.html
7. Almdal T, Scharling H, Jensen J S, et al. The independent effect
of type 2 diabetes mellitus on ischemic heart disease, stroke, and
death: a population-based study of 13 000 men and women with 20 years
of follow-up. Archives of internal medicine. 2004;164:1422-1426.